Detailed information for compound 228213

Basic information

Technical information
  • TDR Targets ID: 228213
  • Name: 2-[[6-[methyl(prop-2-enyl)amino]-9-propan-2-y lpurin-2-yl]amino]ethanol
  • MW: 290.364 | Formula: C14H22N6O
  • H donors: 2 H acceptors: 4 LogP: 1.49 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: OCCNc1nc(N(CC=C)C)c2c(n1)n(cn2)C(C)C
  • InChi: 1S/C14H22N6O/c1-5-7-19(4)12-11-13(20(9-16-11)10(2)3)18-14(17-12)15-6-8-21/h5,9-10,21H,1,6-8H2,2-4H3,(H,15,17,18)
  • InChiKey: SMIYJFXDXQQMIX-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[[6-[allyl(methyl)amino]-9-isopropyl-purin-2-yl]amino]ethanol
  • 2-[[6-[allyl(methyl)amino]-9-isopropyl-2-purinyl]amino]ethanol
  • 2-[[6-[methyl(prop-2-enyl)amino]-9-propan-2-yl-purin-2-yl]amino]ethanol
  • 2-[[6-(methyl-prop-2-enylamino)-9-propan-2-ylpurin-2-yl]amino]ethanol
  • 2-[[6-(allyl-methyl-amino)-9-isopropyl-purin-2-yl]amino]ethanol
  • 2-[[6-(allyl-methylamino)-9-isopropyl-2-purinyl]amino]ethanol
  • 2-[[6-(methyl-prop-2-enyl-amino)-9-propan-2-yl-purin-2-yl]amino]ethanol
  • 2,6,9-Trisubstituted purine deriv. 7

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus granulosus adenosine deaminase 0.7026 1 1
Treponema pallidum adenosine deaminase 0.7026 1 0.5
Mycobacterium leprae Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) 0.7026 1 0.5
Onchocerca volvulus Adenosine deaminase homolog 0.7026 1 1
Schistosoma mansoni adenosine deaminase 0.7026 1 1
Trypanosoma cruzi adenosine monophosphate deaminase, putative 0.4531 0.1393 0.5
Plasmodium falciparum adenosine deaminase 0.7026 1 1
Entamoeba histolytica adenosine deaminase, putative 0.7026 1 1
Loa Loa (eye worm) AMP deaminase 0.4531 0.1393 0.1393
Echinococcus multilocularis adenosine deaminase 0.7026 1 1
Mycobacterium ulcerans adenosine deaminase 0.7026 1 0.5
Trypanosoma brucei AMP deaminase, putative 0.4531 0.1393 0.5
Schistosoma mansoni adenosine deaminase-related 0.7026 1 1
Trypanosoma cruzi AMP deaminase, putative 0.4531 0.1393 0.5
Trypanosoma cruzi AMP deaminase, putative 0.4531 0.1393 0.5
Toxoplasma gondii Adenosine/AMP deaminase domain-containing protein 0.7026 1 1
Plasmodium vivax adenosine deaminase, putative 0.7026 1 1
Loa Loa (eye worm) hypothetical protein 0.7026 1 1
Trypanosoma cruzi AMP deaminase, putative 0.4531 0.1393 0.5
Trichomonas vaginalis adenosine deaminase, putative 0.7026 1 0.5
Toxoplasma gondii Adenosine/AMP deaminase domain-containing protein 0.7026 1 1
Trypanosoma cruzi AMP deaminase, putative 0.4531 0.1393 0.5
Trypanosoma brucei adenosine monophosphate deaminase, putative 0.4531 0.1393 0.5
Entamoeba histolytica adenosine deaminase, putative 0.7026 1 1
Trypanosoma brucei AMP deaminase, putative 0.4531 0.1393 0.5
Trypanosoma cruzi adenosine monophosphate deaminase-like protein, putative 0.4531 0.1393 0.5
Trichomonas vaginalis adenosine deaminase, putative 0.7026 1 0.5
Trypanosoma cruzi AMP deaminase, putative 0.4531 0.1393 0.5
Mycobacterium tuberculosis Probable adenosine deaminase Add (adenosine aminohydrolase) 0.7026 1 0.5
Leishmania major adenine aminohydrolase 0.7026 1 1
Trypanosoma brucei AMP deaminase, putative 0.4531 0.1393 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) > 100 uM Inhibitory activity against Cyclin-dependent kinase 5 ChEMBL. 11063606
IC50 (binding) > 100 uM Inhibitory activity against Cyclin-dependent kinase 5 ChEMBL. 11063606
IC50 (binding) = 150 uM Inhibition of Cyclin-dependent kinase 1 (CDK1) ChEMBL. 11063606
IC50 (binding) = 150 uM Inhibition of Cyclin-dependent kinase 1 (CDK1) ChEMBL. 11063606

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.